Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Recently granted patents

New US pharmaceutical patent grants from the past 12 months — competitive surveillance for BD and IP teams.

Patents
890

Quick answer

890 pharmaceutical patents in our USPTO index were granted within the past year. Browse by grant date with links to applicant company portfolios and related drug profiles.

  1. US 20260108463

    NANOEMULSION FORMULATION WITH IMPROVED TACROLIMUS STABILITY AND SKIN PENETRATION

    BIOFRONTERA BIOSCIENCE GMBH [DE] · Granted Thu Apr 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Apr 18 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. WO 2026082899

    ARN POUR LA PREVENTION OU LE TRAITEMENT DE LA TUBERCULOSE

    BIONTECH SE [DE] · Granted Thu Apr 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Apr 18 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. WO 2026082715

    DÉPLÉTION DES MACROPHAGES ET VIRUS DE LA STOMATITE VÉSICULAIRE POUR LE TRAITEMENT DU CANCER

    BOEHRINGER INGELHEIM INT [DE] · Granted Thu Apr 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Apr 18 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. WO 2026085433

    PROCÉDÉS POUR PRÉPARER DES CONJUGUÉS OLIGONUCLÉOTIDIQUES

    BIOGEN MA INC [US] · Granted Thu Apr 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Apr 18 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. WO 2026078159

    AGENTS D'ACTIVATION DE CELLULES IMMUNITAIRES ET PROCÉDÉS LES COMPRENANT

    ABLYNX NV [BE] · Granted Thu Apr 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Apr 11 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. PT 3886798

    COMBINATION COMPOSITIONS COMPRISING A BETA-LACTAMASE INHIBITOR AND USES THEREOF

    BASILEA PHARMACEUTICA INT AG ALLSCHWIL [CH] · Granted Thu Apr 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Apr 11 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. WO 2026078165

    CONJUGUÉS COMPRENANT DES LIANTS CLIVABLES

    ASTRAZENECA AB [SE] · Granted Thu Apr 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Apr 11 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. WO 2026078163

    CONJUGUÉS COMPRENANT DES LIANTS

    ASTRAZENECA AB [SE] · Granted Thu Apr 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Apr 11 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. WO 2026078615

    ASSOCIATION DE TALAZOPARIB ET D'ENZALUTAMIDE DANS LE TRAITEMENT DU CANCER DE LA PROSTATE MÉTASTATIQUE RÉSISTANT À LA CASTRATION

    PFIZER [US] · Granted Thu Apr 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Apr 11 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. WO 2026078619

    ASSOCIATION DE TALAZOPARIB ET D'ENZALUTAMIDE DANS LE TRAITEMENT DU CANCER DE LA PROSTATE MÉTASTATIQUE RÉSISTANT À LA CASTRATION

    PFIZER [US] · Granted Thu Apr 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Apr 11 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. WO 2026080794

    COMPOSÉS CHIMIQUES UTILES POUR DÉGRADER DES PROTÉINES

    BRISTOL MYERS SQUIBB CO [US] · Granted Thu Apr 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Apr 11 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. WO 2026075941

    DÉRIVÉS DE PYRIDAZINONE EN TANT QU'INHIBITEURS DE PAD4

    BRISTOL MYERS SQUIBB CO [US] · Granted Thu Apr 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Apr 04 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. WO 2026075950

    SCHÉMA POSOLOGIQUE POUR AGENT ANTI-DLL3

    AMGEN INC [US] · Granted Thu Apr 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Apr 04 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 20260096994

    SOLID DISPERSIONS HAVING STABILIZED EMULSION PARTICLES

    BOEHRINGER INGELHEIM INT [DE] · Granted Thu Apr 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Apr 04 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 20260097057

    COMBINATION OF ZIBOTENTAN AND DAPAGLIFLOZIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE AND LIVER FIBROSIS

    ASTRAZENECA AB [SE] · Granted Thu Apr 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Apr 04 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. WO 2026072909

    PROTÉINES DE LIAISON À FLT1 ET MÉTHODES D'UTILISATION

    AMGEN INC [US] · Granted Thu Apr 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Mar 28 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. WO 2026068294

    PROCESSUS DE NANOENSEMENCEMENT AMÉLIORÉ

    BAYER AG [DE] · Granted Thu Apr 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Mar 28 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. AU 2024342196

    NOVEL ECTEINASCIDIN DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF, AND ANTIBODY-DRUG CONJUGATE AND USE THEREOF

    ABBVIE GROUP HOLDINGS LTD [BM] · Granted Thu Apr 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Mar 28 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. WO 2026068864

    DOMAINES CH1 ET CL MODIFIÉS POUR LA PRÉVENTION DU MÉSAPPARIEMENT DE CHAÎNE

    BIONTECH SE [DE] · Granted Thu Apr 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Mar 28 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 20260083736

    GHRELIN O-ACYL TRANSFERASE (GOAT) INHIBITORS FOR USE IN THE TREATMENT OF SUBSTANCE USE DISORDER IN PATIENTS WITH HIGH IMPULSIVITY

    BOEHRINGER INGELHEIM INT [DE] · Granted Thu Mar 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Mar 21 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. WO 2026062193

    COMPOSITIONS ET PROCÉDÉS

    BIONTECH SE [DE] · Granted Thu Mar 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Mar 21 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. WO 2026062071

    ANTAGONISTES DE TNFR1 ET AGONISTES DE TNFR2 POUR LE TRAITEMENT DE LA DOULEUR AIGUË

    RESANO GMBH [DE] · Granted Thu Mar 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Mar 21 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. WO 2026062034

    NANOPARTICULES DE PROTÉINE AFFICHANT DES ANTIGÈNES DE MALADIE DE LYME

    BAVARIAN NORDIC AS [DK] · Granted Thu Mar 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Mar 21 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. WO 2026060131

    ADDITIFS POUR LA PRODUCTION DE VECTEURS VIRAUX

    BIOGEN MA INC [US] · Granted Thu Mar 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Mar 14 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. WO 2026057625

    PEPTIDOGLYCANE HYDROLASES AYANT UN DOMAINE CHAP AVEC SITE ACTIF MODIFIÉ

    BIONTECH SE [DE] · Granted Thu Mar 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Mar 14 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. WO 2026060304

    ADMINISTRATION SOUS-CUTANÉE D'UN AGENT ANTI-DLL3 POUR LE TRAITEMENT DU CANCER

    AMGEN INC [US] · Granted Thu Mar 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Mar 14 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. WO 2026057740

    TRAITEMENT DU CANCER AVEC DES MOLÉCULES DE LIAISON THÉRAPEUTIQUES

    ASTRAZENECA AB [SE] · Granted Thu Mar 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Mar 14 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. WO 2026057588

    POLYTHÉRAPIE À BASE DE CLASCOTÉRONE ET DE MINOXIDIL POUR LE TRAITEMENT DE LA PERTE DES CHEVEUX

    CASSIOPEA S P A [IT] · Granted Thu Mar 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Mar 14 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. WO 2026057582

    COMBINAISONS THÉRAPEUTIQUES D'UN INHIBITEUR D'AKT, D'UN INHIBITEUR DE BCL-2 ET D'UN GLUCOCORTICOÏDE

    ASTRAZENECA AB [SE] · Granted Thu Mar 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Mar 14 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. WO 2026058153

    UTILISATIONS DE RÉCEPTEUR DE LYMPHOCYTES T DE VPH-16 ET COMPOSITIONS ASSOCIÉES

    BIONTECH SE [DE] · Granted Thu Mar 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Mar 14 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. WO 2026057626

    PEPTIDOGLYCANE HYDROLASES AYANT DE MULTIPLES DOMAINES ENZYMATIQUEMENT ACTIFS

    BIONTECH SE [DE] · Granted Thu Mar 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Mar 14 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. WO 2026057739

    POLYTHÉRAPIE COMPRENANT DES ANTICORPS ANTI-CTLA4 ET DES ANTICORPS ANTI-PD-1 POUR LE TRAITEMENT DU CANCER DE L'OVAIRE RÉSISTANT AU PLATINE

    BIONTECH SE [DE] · Granted Thu Mar 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Mar 14 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. WO 2026055127

    PROCÉDÉ DE PRODUCTION D'UN MODULATEUR DE RÉCEPTEUR GABA

    SAGE THERAPEUTICS INC A WHOLLY OWNED SUBSIDIARY OF SUPERNUS PHARMACEUTICALS INC [US] · Granted Thu Mar 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Mar 07 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. WO 2026055477

    COMPOSÉS MACROCYCLIQUES CONSTITUANT DES MODULATEURS DE KRAS ET LEURS UTILISATIONS

    AMGEN INC [US] · Granted Thu Mar 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Mar 07 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. WO 2026052764

    PROCÉDÉ DE NOTATION POUR UNE THÉRAPIE PAR CONJUGUÉ ANTICORPS ANTI-TROP2-MÉDICAMENT

    ASTRAZENECA UK LTD [GB] · Granted Thu Mar 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Mar 07 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. WO 2026046899

    PYRAZOLO[5,1-f][1,2,4]TRIAZIN-4-ONES EN TANT QU'INHIBITEURS DE NOX4

    BOEHRINGER INGELHEIM INT [DE] · Granted Thu Mar 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Feb 28 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 20260060930

    New crystalline Forms, new pharmaceutical Composition and Dose Regimen of a Dipeptidyl peptidase I inhibitor for the Treatment of Patients with Bronchiectasis or other DPP-I mediated Diseases

    BOEHRINGER INGELHEIM INT [DE] · Granted Thu Mar 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Feb 28 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. WO 2026047601

    RÉCEPTEURS DE LYMPHOCYTES T (TCR)

    BIONTECH SE [DE] · Granted Thu Mar 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Feb 28 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. WO 2026047603

    COMPOSITIONS IMMUNOGÈNES CONTRE SARS-COV-2

    BIONTECH SE [DE] · Granted Thu Mar 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Feb 28 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. WO 2026047020

    FORMES CRISTALLINES D'INHIBITEURS DE HER2/MUTEGFR ET LEUR PROCÉDÉ DE PRÉPARATION

    BAYER AG [DE] · Granted Thu Mar 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Feb 28 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. WO 2026047022

    FORME POSOLOGIQUE PHARMACEUTIQUE SOLIDE ET STABLE COMPRENANT UNE FORME CRISTALLINE D'UN INHIBITEUR DE HER2/MUTEGFR ET SA MÉTHODE DE PRÉPARATION

    BAYER AG [DE] · Granted Thu Mar 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Feb 28 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 20260055120

    Bicyclic pyrimidinones as inhibitors of NOX4

    BOEHRINGER INGELHEIM INT [DE] · Granted Thu Feb 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Feb 21 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. WO 2026042803

    UTILISATION D'UN ANTICORPS BISPÉCIFIQUE ANTI-CLDN4/ANTI-CD137 EN COMBINAISON AVEC UN MÉDICAMENT À BASE DE PLATINE POUR LE TRAITEMENT DU CANCER

    ASTELLAS PHARMA INC [JP] · Granted Thu Feb 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Feb 21 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. WO 2026041780

    POLYTHÉRAPIE COMPRENANT DES ANTICORPS ANTI-CTLA4 ET UNE CHIMIOTHÉRAPIE POUR LE TRAITEMENT DU CANCER

    BIONTECH SE [DE] · Granted Thu Feb 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Feb 21 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. WO 2026041123

    VACCINS À VECTEUR DEV CONTRE LA GRIPPE AVIAIRE

    BOEHRINGER INGELHEIM VETMEDICA CHINA CO LTD [CN] · Granted Thu Feb 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Feb 21 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. WO 2026041793

    PROTÉINES CHIMÉRIQUES COMPRENANT DES DOMAINES PROTÉIQUES NON HUMAINS POUR AMÉLIORER L'ANTIGÉNICITÉ

    BIONTECH SE [DE] · Granted Thu Feb 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Feb 21 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. WO 2026044005

    PARTICULES DE VAA COMPRENANT DES PEPTIDES CONTENANT RGD POUR ADMINISTRER DES CHARGES UTILES DE DYSTROPHINE

    BIOGEN MA INC [US] · Granted Thu Feb 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Feb 21 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. WO 2026039306

    BÉTAÏNE ET FOLATE POUR FAVORISER LA MATURATION DU CERVEAU D'UN NOURRISSON

    ABBOTT LAB [US] · Granted Thu Feb 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Feb 14 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How recent are these patent grants?

This hub lists published patents with a grant date within the last 365 days, ordered newest first.

Which patent classes are included?

We index USPTO PatentsView records with pharmaceutical CPC classifications A61K and A61P linked to tracked assignee companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.